Tech Company Financing Transactions

Eiger BioPharmaceuticals Funding Round

On 11/23/2015, Eiger BioPharmaceuticals announced $6 million in funding from private investors.

Transaction Overview

Announced On
11/23/2015
Transaction Type
Debt
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2155 Park Blvd.
Palo Alto, CA 94306
USA
Email Address
Overview
Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.
Profile
Eiger BioPharmaceuticals LinkedIn Company Profile
Social Media
Eiger BioPharmaceuticals Company Twitter Account
Company News
Eiger BioPharmaceuticals News
Facebook
Eiger BioPharmaceuticals on Facebook
YouTube
Eiger BioPharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Cory
  David Cory LinkedIn Profile  David Cory Twitter Account  David Cory News  David Cory on Facebook
Chief Financial Officer
Sri Ryali
  Sri Ryali LinkedIn Profile  Sri Ryali Twitter Account  Sri Ryali News  Sri Ryali on Facebook
VP - Bus. Development
Eldon Mayer
  Eldon Mayer LinkedIn Profile  Eldon Mayer Twitter Account  Eldon Mayer News  Eldon Mayer on Facebook
VP - General Counsel
Stephana Patton
  Stephana Patton LinkedIn Profile  Stephana Patton Twitter Account  Stephana Patton News  Stephana Patton on Facebook
VP - Sales
James Shaffer
  James Shaffer LinkedIn Profile  James Shaffer Twitter Account  James Shaffer News  James Shaffer on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/23/2015: Ruby Ribbon venture capital transaction
Next: 11/23/2015: LogicMonitor venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary